StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > .75 level ii

<< Previous

Bullboard Posts

Next >>

Comment by InvrsContrarianon Nov 27, 2020 3:23pm

124 Views

Post# 31991114

RE:.75 level ii

Speed bump at 78.

2020oilgamble wrote:

  Level ll Quote

  Bid   Ask

  Price   Total Size   # of Orders   Price   Total Size   # of Orders

$0.73 22000 4 $0.75 43500 5

$0.72 1500 1 $0.76 11500 3

$0.71 5500 2 $0.77 44500 4

$0.70 12000 4 $0.78 169000 10

$0.69 40000 4 $0.79 45500 5

$0.68 9000 3 $0.80 45500 8

$0.67 37000 5 $0.81 1000 1

$0.66 149500 6 $0.82 12000 6

$0.65 27500 3 $0.83 1500 1

$0.64 93000 9 $0.84 2000 1

Last: 0.75 Change: 0.09 Volume: 834,768 Last Trade: 15:19